Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Gagnon Suzanne, Director. Officer active across 1 company, notably Panbela Therapeutics, Inc.. In total, 1 disclosures have been logged. History available since 6 January 2021. The latest transaction was filed on 6 January 2021 (Don). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Suzanne Gagnon is a Director at Panbela Therapeutics, Inc. She contributes to the governance of the company through her expertise in the pharmaceutical sector. As a board member, she participates in strategy development and oversight of operations, aiming to promote innovation and growth.